Slade & Baker Vision Center is constantly being sought out by device and pharmaceutical companies to conduct clinical trials in order to help them gain FDA approval. Often, patients who are eligible for these clinical trials receive significant discounts for their participation. Current clinical trials being conducted at Slade & Baker Vision Center are listed below. Please call our office to learn more.
Slade & Baker Vision is currently conducting a medical research study for people who have at least one eye that has impaired vision, who don’t see well, or may not be able to see at all even with glasses or contacts. The purpose of this study is to collect data on the basic safety and function of an investigational laser when used on people’s eyes. Participation would involve laser surgery on your eye with limited vision and at least 7 visits to our clinic.
You may qualify to participate in this research study IF:
- You are at least 22 years of age or older
- You have limited vision in at least one of your eyes
- Your eye with limited vision:
- Has not had previous surgery on the front of the eye (the cornea)
- Has not had cataract surgery
If you are interested in participating, please contact:
Hospital/Site: Slade & Baker Vision
Contact Person Name: Chadisty Pauly or Beverly Socop
Phone Number: 713-626-5544
UPDATE: We will be introducing some new PRK trials in the near future. If you are interested, please contact us by calling 713-626-5544 or sending us a quick email to: email@example.com.
If you are interested in participating in a current or future clinical trial listed above, please let us know by filling out the details in the contact form at the bottom of this page!
~ COMPLETED OR APPROVED TRIALS ~
UPDATE: We have completed enrollment!
Carl Zeiss Meditec and Slade & Baker Vision Center were conducting a research study on a new laser procedure, SMILE, designed to correct nearsightedness and astigmatism.
SMILE is an alternative to LASIK and designed to accomplish the same visual result as the LASIK procedure. It was finally FDA approved!
- You have nearsightedness with astigmatism
- You are at least 22 years of age
- You have had no previous eye surgery, significant trauma or infections in either of your eyes.
- You have a pair of glasses that are at least 1 year old
- You are in good general health
- You are willing to take your contact lenses out several weeks before surgery.
If you are all of the above and want to see if you are a candidate for SMILE, please call 713-626-5544.
Corneal Crosslinking (CXL)
NO LONGER A TRIAL – APPROVED
UPDATE: As of April 2016, Corneal Crosslinking CXL is now APPROVED in the US by the FDA! Slade & Baker Vision Center was the first site in Texas to perform corneal cross linking as part of a clinical trial. We are excited to announce that this trial has ended and CXL is now a regularly approved procedure in the US. We offer screening evaluations, at no charge, for patients with corneal ectasia and/or KERATOCONUS to find out their options.
CXL is designed to treat Keratoconus, a disease that results in increasing nearsightedness and astigmatism. CXL may also be used to treat certain complications after refractive surgery (i.e. LASIK or PRK), primarily Post Lasik Ectasia patients that experience corneal thinning after Refractive Surgery. CXL treatment consists of a combination of applying Riboflavin drops, a B vitamin, to the front surface of the eye along with the use of an ultraviolet light. CXL has been approved in other parts of the world for multiple years and has now finally been approved in the US this year (2016). Dr. Slade was a lead investigator for the FDA Study that gained approval for this procedure. While any procedure, even wearing contact lenses, carries some risks, CXL is associated with low risks. In the other parts of the world, where CXL has been approved for years, results have been excellent.
The best first step is to come in to the clinic for a screening evaluation to find out if you are eligible. Please visit our corneal crosslinking page to learn more. We look forward to seeing you!
Raindrop® – Near Vision Corneal Inlay for Presbyopia
APPROVED – NO LONGER A TRIAL
The Raindrop Clinical Study was being conducted at several specialized ophthalmology centers throughout the U.S. Slade & Baker Vision Center was the only site in Houston, TX where the clinical trial had been offered and as of August 30th 2016, Dr. Slade was the first surgeon in the US to perform the procedure outside of the clinical trials which was live streamed! This was previously referred to as the “Presbylens” study.
Our research coordinator, Chadisty Pauly was recently honored by Revision Optics as the Research Coordinator of the year for the Raindrop study we participated in.
Fueled by a belief that no one should ever have to hold a menu out at arm’s length, RVO developed the Raindrop® Near Vision Corneal Inlay, a unique patented refractive surgery solution. This inlay is designed to improve the near vision that has been lost by the eye’s natural aging process, presbyopia. The Company is actively pursuing regulatory approvals for Raindrop® worldwide, and is committed to ridding the world of reading glasses, one satisfied patient at a time which is why Slade & Baker Vision Center has joined forces and offered this procedure to their patients.
Presbyopia is the loss of near vision with age and it typically happens to everyone over 40 years of age. The Raindrop procedure consists of the creation of a small LASIK-like flap made with a laser; the inlay is laid on the cornea under the flap; and the corneal flap is returned to its original position where it bonds without stitches. No corneal tissue is removed and the lens is removable if needed. This technique has been approved in Europe and we assisted in finally gaining its approval this month (July 2016) in the US! If you or a loved one has developed presbyopia, please visit our Raindrop Corneal Inlay page for more information on this procedure or call us at 713-626-5544 to set up an appointment.
This LASIK study was for patients who are nearsighted, farsighted or have astigmatism. In this study we used a new, custom LASIK treatment pattern. The treatment pattern had been approved in Europe and we were assisting in gaining its approval in the US. Early results were impressive. A significant reduction in the cost for LASIK was provided to patients for their participation. Qualifying patients were 18 years of age or older.
~ CURRENT & FUTURE CLINICAL TRIALS ~
If you are interested in participating in a current or future clinical trial, please let us know by filling out the details below!